Journal
MOLECULES
Volume 24, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/molecules24020314
Keywords
antimicrobial; xanthones; chirality; chiral derivatives of xanthones; caged xanthones
Funding
- Fundacao da Ciencia e Tecnologia (FCT/MCTES, PIDDAC) [PTDC/MAR-BIO/4694/2014, PTDC/AAG-TEC/0739/2014]
- European Regional Development Fund (ERDF) through the COMPETE-Programa Operacional Factores de Competitividade (POFC) programme [POCI-01-0145-FEDER-016790, POCI-01-0145-FEDER-016793]
- Reforcar a Investigacao, o Desenvolvimento Tecnologico e a Inovacao (RIDTI) [3599, 9471]
- COMPETE 2020, Portugal 2020 [POCI-01-0145-FEDER-028736]
- European Union through the ERDF
- FCT
- CHIRALXANT-CESPU-2018
- Fundação para a Ciência e a Tecnologia [PTDC/AAG-TEC/0739/2014, PTDC/MAR-BIO/4694/2014] Funding Source: FCT
Ask authors/readers for more resources
According to the World Health Organization, the exacerbated use of antibiotics worldwide is increasing multi-resistant infections, especially in the last decade. Xanthones are a class of compounds receiving great interest in drug discovery and development that can be found as natural products or obtained by synthesis. Many derivatives of xanthones are chiral and associated with relevant biological activities, including antimicrobial. The aim of this review is to compile information about chiral derivatives of xanthones from natural sources and their synthesized examples with antimicrobial activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available